Home/Filings/4/0000950170-25-037516
4//SEC Filing

Murray Dallan 4

Accession 0000950170-25-037516

CIK 0000873303other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 8:00 PM ET

Size

14.3 KB

Accession

0000950170-25-037516

Insider Transaction Report

Form 4
Period: 2025-03-07
Murray Dallan
Chief Customer Officer
Transactions
  • Tax Payment

    Common Stock

    2025-03-10$100.13/sh996$99,72932,663 total
  • Exercise/Conversion

    Performance Stock Units

    2025-03-075,5000 total
    Common Stock (5,500 underlying)
  • Exercise/Conversion

    Common Stock

    2025-03-07+5,50033,659 total
  • Tax Payment

    Common Stock

    2025-03-10$100.13/sh2,737$274,05629,926 total
  • Award

    Common Stock

    2025-03-10+8,27638,202 total
  • Award

    Stock Options (right to buy)

    2025-03-10+16,64416,644 total
    Exercise: $99.69From: 2026-03-10Exp: 2035-03-10Common Stock (16,644 underlying)
Footnotes (5)
  • [F1]Represents the number of shares vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU.
  • [F2]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022.
  • [F3]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 7, 2022.
  • [F4]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
  • [F5]Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.

Documents

1 file

Issuer

Sarepta Therapeutics, Inc.

CIK 0000873303

Entity typeother

Related Parties

1
  • filerCIK 0002022303

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 8:00 PM ET
Size
14.3 KB